The overall ratings of four Medical Devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
This week, Quidel Corp. (NASDAQ:QDEL) falls to a D (“sell”), worse than last week’s grade of C (“hold”). Quidel discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. In Portfolio Grader’s specific subcategories of Earnings Revisions and Margin Growth, QDEL also gets F’s. As of Nov. 19, 2012, 15.2% of outstanding Quidel Corp. shares were held short. For a full analysis of QDEL stock, visit Portfolio Grader.
Cerus (NASDAQ:CERS) earns a D this week, falling from last week’s grade of C. Cerus is a biomedical products company engaged in the development and commercialization of the INTERCEPT Blood System. The stock gets F’s in Equity and Cash Flow. The stock price has fallen 14.2% over the past month, worse than the 7.2% decrease the Nasdaq has seen over the same period of time. As of Nov. 19, 2012, 11.3% of outstanding Cerus shares were held short. For more information, get Portfolio Grader’s complete analysis of CERS stock.
The rating of Tornier (NASDAQ:TRNX) declines this week from a C to a D. Tornier designs, outsources the manufacture of and markets orthopedic products. The stock gets F’s in Earnings Momentum, Earnings Revisions, and Equity. For a full analysis of TRNX stock, visit Portfolio Grader.
Unilife (NASDAQ:UNIS) earns a F (“strong sell”) this week, moving down from last week’s grade of D (“sell”). Unilife Medical Solutions specializes in the design, development and supply of safety medical devices. In Earnings Revisions, Equity, Cash Flow, and Sales Growth the stock gets F’s. As of Nov. 19, 2012, 11% of outstanding Unilife shares were held short. To get an in-depth look at UNIS, get Portfolio Grader’s complete analysis of UNIS stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.